Finance

Beta
Lists
002262:SHE
Jiangsu Nhwa Pharmaceutical Co., LTD
CNÂ¥19.32
-0.57%
(-0.11) 1D
Jun 5, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002262...
Open
CNÂ¥19.53
High
CNÂ¥19.68
Low
CNÂ¥19.29
Mkt. cap
19.62B
Avg. vol.
10.82M
Volume
7.24M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 26, 2026
P/E ratio
18.30
52-wk high
CNÂ¥29.30
52-wk low
CNÂ¥19.13
EPS
CNÂ¥1.06
Shares outstanding
1.02B
No. of employees
6K
Open
CNÂ¥19.53
High
CNÂ¥19.68
Low
CNÂ¥19.29
Mkt. cap
19.62B
Avg. vol.
10.82M
Volume
7.24M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 26, 2026
P/E ratio
18.30
52-wk high
CNÂ¥29.30
52-wk low
CNÂ¥19.13
EPS
CNÂ¥1.06
Shares outstanding
1.02B
No. of employees
6K
News stories
From sources across the web
About Jiangsu Nhwa Pharmaceutical Co., LTD
CEO-
Employees6K
Founded1978
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.50B
1.46B
1.44B
1.61B
Cost of goods sold
372.61M
317.02M
606.11M
467.50M
Cost of revenue
372.61M
317.02M
606.11M
467.50M
Research and development expenses
143.74M
176.94M
172.85M
156.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
537.89M
517.01M
740.60M
609.48M
Operating expense
688.01M
707.79M
930.59M
799.18M
Total operating expenses
1.06B
1.02B
1.54B
1.27B
Operating income
438.61M
436.06M
-96.50M
343.58M
Other non operating income
-3.05M
-8.77M
11.13M
-1.02M
EBT including unusual items
452.07M
445.15M
-60.47M
355.72M
EBT excluding unusual items
450.66M
450.14M
-68.49M
361.66M
Income tax expense
52.66M
40.68M
-10.85M
38.12M
Effective tax rate
11.65%
9.14%
17.94%
10.72%
Other operating expenses
15.16M
12.62M
18.65M
17.44M
Net income
399.79M
405.55M
-48.71M
317.41M
Net profit margin
26.67%
27.76%
-3.38%
19.71%
Earnings per share
0.39
0.40
-0.04
0.31
Interest and investment income
15.15M
24.11M
18.37M
19.53M
Interest expense
-570.17K
-733.66K
-460.07K
-426.65K
Net interest expenses
14.58M
23.37M
17.91M
19.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
480.06M
473.85M
-54.20M
385.87M
Gain or loss from assets sale
-41.86K
41.86K
-165.79K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more